Clinical trial
Double-blind, Placebo-controlled Clinical Trial on the Efficacy of Antireflux Ablation of the Cardiac Mucosa for the Treatment of Gastroesophageal Reflux Disease
NCT04711655 is registered in ClinicalTrials.gov with Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Placebo-controlled Clinical Trial on the Efficacy of Antireflux Ablation of the Cardiac Mucosa for the Treatment of Gastroesophageal Reflux Disease
- Lead sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- February 7, 2025
- Enrollment
- 64 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
gastroesophageal reflux disease